Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-195,000
Closed -$29.6M 4304
2017
Q2
$29.6M Buy
+195,000
New +$27.6M 0.03% 611
2016
Q3
Sell
-912,900
Closed -$111M 4351
2016
Q2
$111M Sell
912,900
-301,800
-25% -$34.7M 0.12% 157
2016
Q1
$136M Buy
1,214,700
+806,100
+197% +$86.3M 0.16% 115
2015
Q4
$44.2M Sell
408,600
-476,900
-54% -$51.6M 0.05% 422
2015
Q3
$96.9M Buy
885,500
+879,100
+13,736% +$102M 0.12% 179
2015
Q2
$816K Sell
6,400
-205,700
-97% -$23.5M ﹤0.01% 3359
2015
Q1
$22.6M Buy
212,100
+112,100
+112% +$11M 0.02% 756
2014
Q4
$8.88M Sell
100,000
-324,900
-76% -$27.3M 0.01% 1358
2014
Q3
$34.4M Buy
+424,900
New +$34.6M 0.03% 670

Other funds holding AET

Credit Suisse's AET Position: Q4 2018 in Review

Credit Suisse sold out of Aetna Inc (AET) in Q4 2018, closing a stake of 552,685 shares — an estimated $112M sold.

Credit Suisse first reported a position in AET in Q2 2013 and held it in 22 quarters. The position peaked at $247M in Q4 2015. 6 funds tracked by Wall St. Rank hold AET as of Q4 2018.

  • Credit Suisse reported no remaining Aetna Inc position as of Q4 2018 after selling out during the quarter.
  • Credit Suisse sold 552,685 Aetna Inc shares in Q4 2018, an estimated $112M.
  • Credit Suisse first reported a position in Aetna Inc in Q2 2013 and held it in 22 quarters.
  • Credit Suisse's Aetna Inc position peaked at $247M in Q4 2015.
  • 6 funds tracked by Wall St. Rank held Aetna Inc as of Q4 2018.

Based on Credit Suisse's 13F filing for Q4 2018, filed 13 Feb 2019.